Bone marrow mononuclear cells have neurovascular tropism and improve diabetic neuropathy

Stem Cells

Volumn 27, Issue 7, 2009, Pages 1686-1696

  Kim, Hyongbum ^a,b   Park, Jong Seon ^b   Yong, Jin Choi ^a,b   Kim, Mee Ohk ^a,b   Yang, Hoon Huh ^c   Kim, Sung Whan ^a,b   Ji, Woong Han ^a   Lee, JiYoon ^a,b   Kim, Sinae ^a   Houge, Mackenzie A ^a   Ii, Masaaki ^b   Yoon, Young Sup ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Angiogenesis; Angiogenic factors; Bone marrow mononuclear cells; Diabetes; Diabetic neuropathy; Neurotrophic factors

Indexed keywords

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; ENGRAFTMENT; MONONUCLEAR CELL; MOTOR NERVE; NERVE CONDUCTION; NEUROVASCULAR ISLAND FLAP; NONHUMAN; PLANT GROWTH; RAT; REAL TIME POLYMERASE CHAIN REACTION; SENSORY NERVE;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; DIABETIC NEUROPATHIES; HEMODYNAMICS; IMMUNOPHENOTYPING; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASA NERVORUM;

RATTUS;

EID: 68049147746     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.87     Document Type: Article

References (61)

1. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world - a growing challenge. N Engl J Med 2007;356:213-215. (Pubitemid 46143224)
2. Leinninger GM, Vincent AM, Feldman EL. The role of growth factors in diabetic peripheral neuropathy. J Peripher Nerv Syst 2004;9:26-53. (Pubitemid 38338438)
3. Tomlinson DR, Fernyhough P, Diemel LT. Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors. Diabetes 1997;46(suppl 2):S43-S49. (Pubitemid 27377397)
4. Vileikyte L. Diabetic foot ulcers: A quality of life issue. Diabetes Metab Res Rev 2001;17:246-249. (Pubitemid 32821657)
5. Cullum NA, Mahon J, Stringer K et al. Glycation of rat sciatic nerve tubulin in experimental diabetes mellitus. Diabetologia 1991;34:387-389.
6. Greene DA, Lattimer SA, Sima AA. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 1987;316:599-606.
7. Cameron NE, Cotter MA. The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes Metab Rev 1994;10:189-224.
8. Pop-Busui R, Sima A, Stevens M. Diabetic neuropathy and oxidative stress. Diabetes Metab Res Rev 2006;22:257-273.
9. Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes 2005;54:1615-1625. (Pubitemid 40770750)
10. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820. (Pubitemid 34000785)
11. Leinninger GM, Edwards JL, Lipshaw MJ et al. Mechanisms of disease: Mitochondria as new therapeutic targets in diabetic neuropathy. Nat Clin Pract Neurol 2006;2:620-628. (Pubitemid 44614088)
12. Tuck RR, Schmelzer JD, Low PA. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 1984;107:935-950.
13. Schratzberger P, Walter DH, Rittig K et al. Reversal of experimental diabetic neuropathy by VEGF gene transfer. J Clin Invest 2001;107:1083-1092. (Pubitemid 32422905)
14. Kusano KF, Allendoerfer KL, Munger W et al. Sonic hedgehog induces arteriogenesis in diabetic vasa nervorum and restores function in diabetic neuropathy. Arterioscler Thromb Vasc Biol 2004;24:2102-2107. (Pubitemid 39482437)
15. Ii M, Nishimura H, Kusano KF et al. Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy. Circulation 2005;112:93-102. (Pubitemid 40962574)
16. Anand P. Neurotrophic factors and their receptors in human sensory neuropathies. Prog Brain Res 2004;146:477-492. (Pubitemid 37541400)
17. Apfel SC. Neurotrophic factors in the therapy of diabetic neuropathy. Am J Med 1999;107:34S-42S.
18. Schmidt RE, Dorsey DA, Beaudet LN et al. Insulin-like growth factor I reverses experimental diabetic autonomic neuropathy. Am J Pathol 1999;155:1651-1660.
19. Zhuang HX, Snyder CK, Pu SF et al. Insulin-like growth factors reverse or arrest diabetic neuropathy: Effects on hyperalgesia and impaired nerve regeneration in rats. Exp Neurol 1996;140:198-205.
20. Mizisin AP, Vu Y, Shuff M et al. Ciliary neurotrophic factor improves nerve conduction and ameliorates regeneration deficits in diabetic rats. Diabetes 2004;53:1807-1812. (Pubitemid 38857039)
21. Anitha M, Gondha C, Sutliff R et al. GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway. J Clin Invest 2006;116:344-356. (Pubitemid 43228351)
22. Lazarovici P, Marcinkiewicz C, Lelkes PI. Cross talk between the cardiovascular and nervous systems: Neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF) - implications in drug development. Curr Pharm Des 2006;12:2609-2622.
23. Simovic D, Isner JM, Ropper AH et al. Improvement in chronic ischemic neuropathy after intramuscular phVEGF165 gene transfer in patients with critical limb ischemia. Arch Neurol 2001;58:761-768. (Pubitemid 32423048)
24. Salis MB, Graiani G, Desortes E et al. Nerve growth factor supplementation reverses the impairment, induced by type 1 diabetes, of hindlimb post-ischaemic recovery in mice. Diabetologia 2004;47:1055-1063. (Pubitemid 38918165)
25. Graiani G, Emanueli C, Desortes E et al. Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of type 1 diabetic mice. Diabetologia 2004;47:1047-1054. (Pubitemid 38918164)
26. Emanueli C, Salis MB, Pinna A et al. Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs. Circulation 2002;106:2257-2262. (Pubitemid 35222222)
27. Kermani P, Rafii D, Jin DK et al. Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors. J Clin Invest 2005;115:653-663. (Pubitemid 40322239)
28. Kim H, Li Q, Hempstead BL et al. Paracrine and autocrine functions of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in brain-derived endothelial cells. J Biol Chem 2004;279:33538-33546. (Pubitemid 39063002)
29. Chen J, Zacharek A, Zhang C et al. Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice. J Neurosci 2005;25:2366-2375. (Pubitemid 40322278)
30. Unsicker K, Reichert-Preibsch H, Schmidt R et al. Astroglial and fibroblast growth factors have neurotrophic functions for cultured peripheral and central nervous system neurons. Proc Natl Acad Sci U S A 1987;84:5459-5463.
31. Lenhard T, Schober A, Suter-Crazzolara C et al. Fibroblast growth factor-2 requires glial-cell-line-derived neurotrophic factor for exerting its neuroprotective actions on glutamate-lesioned hippocampal neurons. Mol Cell Neurosci 2002;20:181-197. (Pubitemid 34762130)
32. Kamihata H, Matsubara H, Nishiue T et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001;104:1046-1052. (Pubitemid 32803883)
33. Shintani S, Murohara T, Ikeda H et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001;103:2776-2779. (Pubitemid 32550062)
34. Tateishi-Yuyama E, Matsubara H, Murohara T et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: A pilot study and a randomised controlled trial. Lancet 2002;360:427-435. (Pubitemid 34884192)
35. Kalka C, Masuda H, Takahashi T et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000;97:3422-3427. (Pubitemid 30183318)
36. Kawamoto A, Gwon HC, Iwaguro H et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001;103:634-637. (Pubitemid 32144189)
37. Kinnaird T, Stabile E, Burnett MS et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 2004;94:678-685. (Pubitemid 38387752)
38. Kinnaird T, Stabile E, Burnett MS et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004;109:1543-1549. (Pubitemid 38420184)
39. Urbich C, Dimmeler S. Endothelial progenitor cells: Characterization and role in vascular biology. Circ Res 2004;95:343-353. (Pubitemid 39100452)
40. Cho HJ, Lee N, Lee JY et al. Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J Exp Med 2007;204:3257-3269.
41. Wang L, Fortune B, Cull G et al. Microspheres method for ocular blood flow measurement in rats: Size and dose optimization. Exp Eye Res 2007;84:108-117. (Pubitemid 44792056)
42. Alexandre CS, Volpini RA, Shimizu MH et al. Lineage-negative bone marrow cells protect against chronic renal failure. Stem Cells 2009;27:682-692.
43. Hasegawa T, Kosaki A, Shimizu K et al. Amelioration of diabetic peripheral neuropathy by implantation of hematopoietic mononuclear cells in streptozotocin-induced diabetic rats. Exp Neurol 2006;199:274-280. (Pubitemid 43928955)
44. Van Oosterhout MF, Willigers HM, Reneman RS et al. Fluorescent microspheres to measure organ perfusion: Validation of a simplified sample processing technique. Am J Physiol 1995;269:H725-H733.
45. Jeong JO, Kim MO, Kim H et al. Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy. Circulation 2009;119:699-708.
46. National Diabetes Statistics. 2007. National Diabetes Information Clearinghouse. Available at http://diabetes.niddk.nih.gov/dm/pubs/statistics/ index.htm#people. Accessed May 9, 2009.
47. Zacchigna S, Lambrechts D, Carmeliet P. Neurovascular signalling defects in neurodegeneration. Nat Rev Neurosci 2008;9:169-181.
48. Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-674.
49. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967. (Pubitemid 27087709)
50. Bertolini F, Shaked Y, Mancuso P et al. The multifaceted circulating endothelial cell in cancer: Towards marker and target identification. Nat Rev Cancer 2006;6:835-845. (Pubitemid 44629895)
51. Yancopoulos GD, Davis S, Gale NW et al. Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242-248.
52. Naruse K, Hamada Y, Nakashima E et al. Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy. Diabetes 2005;54:1823-1828. (Pubitemid 40770773)
53. Shintani S, Murohara T, Ikeda H et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 2001;103:897-903. (Pubitemid 32163891)
54. Imitola J, Raddassi K, Park KI et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A 2004;101:18117-18122. (Pubitemid 40054083)
55. Park KI, Ourednik J, Ourednik V et al. Global gene and cell replacement strategies via stem cells. Gene Ther 2002;9:613-624. (Pubitemid 34575317)
56. Park KI, Teng YD, Snyder EY. The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat Biotechnol 2002;20:1111-1117.
57. Otsuru S, Tamai K, Yamazaki T et al. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Stem Cells 2008;26:223-234.
58. Beeres SL, Bax JJ, Dibbets-Schneider P et al. Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction. Am J Cardiol 2007;100:1094-1098. (Pubitemid 47404464)
59. Hernández P, Cortina L, Artaza H et al. Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: A comparison of using blood cell separator and Ficoll density gradient centrifugation. Atherosclerosis 2007;194:e52-e56. (Pubitemid 47513071)
60. Lunde K, Solheim S, Forfang K et al. Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: Safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up. J Am Coll Cardiol 2008;51:674-676. (Pubitemid 351187971)
61. Lyra AC, Soares MB, da Silva LF et al. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroenterol 2007;13:1067-1073.